|
Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection Rappaport J, et al.
Biomedicine & Pharmacotherapy
2003 Jan;57(1):4-14
Link The results demonstrate that higher levels of serum anti-Tat IgG, but not anti-Vpr IgG, are associated with maintenance of non-progression status in HIV-1 infection. Evidence that vaccination with the Tat toxoid induces humoral immune responses to Tat similar to those observed in stable non-progressors is encouraging for vaccine strategies targeting Tat. (vaccines)
—Posted: April 26, 2003
More journal headlines: This month | Last month | Search archive
|
